Placebo for BMS-936559: Clinical Trials

1 trial of Placebo for BMS-936559, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 completed. 1 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 11Completed 1

Follow Placebo for BMS-936559: new trials by email Literature Review of Placebo for BMS-936559 trials Research Report on Placebo for BMS-936559

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Safety and Immune Response of BMS-936559 in HIV-Infected People Taking Combination Antiretroviral Therapy
BMS-936559, Placebo for BMS-936559 - HIV Infections
Phase 1CompletedNational Institute of Allergy and Infectious Diseases (NIAID)82014-06-012021-11-05

Conditions studied

HIV Infections (1)

Sponsors

National Institute of Allergy and Infectious Diseases (NIAID) (1)

Countries

United States (1)

Top investigators

Joseph Eron Jr., MD (1)

Results publications

PMID 28431010